The North American brachytherapy market is anticipated to grow at a CAGR of 3.3% during the forecast period. As brachytherapy is one type of radiation therapy used to treat cancer, the growing number of cancer patients is augmenting the demand for brachytherapy in the region.
Browse the full report description North American Brachytherapy Market Size, Share & Trends Analysis Report by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), and by Type (Low-Dose Rate (LDR) Brachytherapy and High-Dose Rate (HDR) Brachytherapy) Forecast Period, 2020-2026 at https://www.omrglobal.com/industry-reports/north-american-brachytherapy-market
According to the American Cancer Society, Inc., cancer is the leading cause of mortality in Canada and the second-leading cause in the US. About 1.9 million new cancer cases and 693,000 cancer mortality were estimated to have occurred in North America in 2018. High incidence and mortality due to cancer create significant demand for innovative therapy such as brachytherapy to treat cancer in the region.
Moreover, the market players are contributing considerably to the market growth by adopting various strategies. For instance, Hologic, Inc. had acquired Biotheranostics, SOMATEX, and Mobidiag in 2021 for around $1.1 billion. This acquisition had enhanced the breast and metastatic cancer testing product portfolio of Hologic.
Market Coverage
o By Indication
o By Type
o United States
o Canada
Key Questions Addressed by the report
North American Brachytherapy Market Report Segment
By Indication
By Type
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/north-american-brachytherapy-market